Manon Ansart
6
Documents
Identifiants chercheurs
- manon-ansart
- 0000-0002-0703-2908
- Google Scholar : https://scholar.google.fr/citations?hl=en&user=kRhAAQIAAAAJ
Présentation
Publications
- 6
- 6
- 6
- 4
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 6
|
Predicting the Progression of Mild Cognitive Impairment Using Machine Learning: A Systematic, Quantitative and Critical ReviewMedical Image Analysis, 2021, 67, pp.101848. ⟨10.1016/j.media.2020.101848⟩
Article dans une revue
hal-02337815v2
|
|
Ensemble Learning of Convolutional Neural Network, Support Vector Machine, and Best Linear Unbiased Predictor for Brain Age Prediction: ARAMIS Contribution to the Predictive Analytics Competition 2019 ChallengeFrontiers in Psychiatry, 2020, 11, ⟨10.3389/fpsyt.2020.593336⟩
Article dans une revue
hal-03136463v1
|
|
Reduction of recruitment costs in preclinical AD trials. Validation of automatic pre-screening algorithm for brain amyloidosisStatistical Methods in Medical Research, 2019, pp.096228021882303. ⟨10.1177/0962280218823036⟩
Article dans une revue
hal-01964942v2
|
|
Prediction of future cognitive scores and dementia onset in Mild Cognitive Impairment patientsOHBM 2019 - Organization for Human Brain Mapping Conference, Jun 2019, Rome, Italy
Communication dans un congrès
hal-02098427v2
|
|
Prediction of amyloidosis from neuropsychological and MRI data for cost effective inclusion of pre-symptomatic subjects in clinical trialsMultimodal Learning for Clinical Decision Support, Sep 2017, Quebec City, Canada
Communication dans un congrès
hal-01578422v1
|
|
Selection of amyloid positive pre-symptomatic subjects using automatic analysis of neuropsychological and MRI data for cost effective inclusion procedures in clinical trialsClinical Trials for Alzheimer's Disease, Nov 2017, Boston, United States. pp.295
Communication dans un congrès
hal-02098434v2
|